{"name":"Industrial Microbiology LLP","slug":"industrial-microbiology-llp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"\"AS-Probionorm\"","genericName":"\"AS-Probionorm\"","slug":"as-probionorm","indication":"Gastrointestinal health maintenance","status":"marketed"}]}],"pipeline":[{"name":"\"AS-Probionorm\"","genericName":"\"AS-Probionorm\"","slug":"as-probionorm","phase":"marketed","mechanism":"AS-Probionorm is a probiotic formulation that restores beneficial gut microbiota to support digestive health and immune function.","indications":["Gastrointestinal health maintenance","Digestive support"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNbVl4MHk2YmJ2bnZISjlaUGRwMHZhdjhEcTdjQzRSSlVZRmQ3MXRyWlVYUGhoVUw0Uk80TkpTcVdfYzZENnFtZXdLa1VoUTRCQmF1WS03aE9TeUdxLXVBemN1c3hBbll6UzBEZ2FJck1JSUhKX2k3YVBkWWlXNjNjSlRza2NxZUtqa1lwbzUwSUNUSDk0a0E?oc=5","date":"2025-11-18","type":"pipeline","source":"Trade Brains","summary":"Pharma stock in focus after promoter increases stake in the company - Trade Brains","headline":"Pharma stock in focus after promoter increases stake in the company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNOEtKNkNBbnhSQjV6a0I3cnRMeEdQdTVYako4ZG9TSWVxY2lPUDU0eUVFTi1UM0tXcDZRVEk1SnJXWllBNW55bkR1eUs5cUpzdWZ6a2JDZ1dLbjhQLUpXaW0wemEwdUtrWWFkTjI4XzFvazJjTEFVRWd4d1hhWF93TkpCN0xyR21qb0dpQlZJSmZOWXc2MlhQQUxTM0VJYnBMSkZhajRGd3ZfelJjM1JEY0VjR2djME1QVW12Nk50OVBnZTBMZlk4RlpKWWRGZW1sVFhaLTNn?oc=5","date":"2024-05-29","type":"pipeline","source":"Microbioz India","summary":"Chromcore Lifesciences LLP and Aptar Pharma India Form Strategic Alliance to Enhance Pharmaceutical Development - Microbioz India","headline":"Chromcore Lifesciences LLP and Aptar Pharma India Form Strategic Alliance to Enhance Pharmaceutical Development","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}